See the detailed report:
https://www.fortunebusinessins....ights.com/huntington
Huntington's disease (HD) is a rare genetic disorder that causes the progressive degeneration of nerve cells in the brain, leading to a range of physical, cognitive, and psychiatric symptoms. There is currently no cure for HD, and treatment focuses on managing symptoms and improving quality of life.
The HD treatment market includes a range of therapies aimed at managing symptoms and slowing disease progression. Some of the commonly used treatments include drugs that regulate dopamine levels in the brain, such as tetrabenazine and deutetrabenazine, and drugs that manage psychiatric symptoms, such as antidepressants and antipsychotics.

 

www.fortunebusinessinsights.com

Huntington’s Disease Treatment Market Share & Growth [2030]

The global huntington’s disease treatment market size is projected to grow from $945.8 million in 2023 to $2,932.2 million by 2030, at a CAGR of 17.5%